Clinical Trial Update: Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults [Phase 4]

View source ↗

Summary

Phase 4 study assessing exenatide to treat weight gain associated with olanzapine in obese adults; results were posted on 2018-04-20.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• EXENATIDE (EXENATIDE)
• olanzapine (olanzapine)

Snippet

Sponsor: University of Cincinnati | Conditions: Weight Gain | Phase 4 | Status: COMPLETED | Results posted: 2018-04-20